Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.70 |
| ▸ | HBB | P68871 | 2/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.69 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.66 |
| ▸ | BLM | P54132 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | VCP | P55072 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | HPRT1 | P00492 | 11/20 | 0.52 |
| ▸ | PNP | P00491 | 2/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | EDNRA | P25101 | 1/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Valomaciclovir SCHEMBL711293 | 1.00 | MEN1 (0.70) | MEN1KMT2AHBBMAPK1PDE3A | |
| SCHEMBL711556 | 0.93 | MEN1 (0.70) | MEN1KMT2AHBBMAPK1PDE3A | |
| SCHEMBL711557 | 0.93 | MEN1 (0.70) | MEN1KMT2AHBBMAPK1PDE3A | |
| SCHEMBL8447226 | 0.93 | MEN1 (0.70) | MEN1KMT2AHBBMAPK1PDE3A | |
| SCHEMBL711558 | 0.93 | MEN1 (0.70) | MEN1KMT2AHBBMAPK1PDE3A | |
| SCHEMBL712389 | 0.92 | MEN1 (0.59) | MEN1KMT2AHBBMAPK1PDE3A | |
| SCHEMBL3699745 | 0.92 | MEN1 (0.59) | MEN1KMT2AHBBMAPK1PDE3A | |
| SCHEMBL712388 | 0.92 | MEN1 (0.59) | MEN1KMT2AHBBMAPK1PDE3A | |
| SCHEMBL14595282 | 0.91 | MEN1 (0.68) | MEN1KMT2AHBBMAPK1PDE3A | |
| SCHEMBL7750986 | 0.90 | PDE3A (0.73) | MEN1KMT2AHBBMAPK1PDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4611757-A1 | VIRAL PROPHYLAXIS TREATMENT METHODS AND PRE-EXPOSURE PROPHYLAXIS KITS | Ramirez, Christina, M. (US) | 2025-09-10 | — | — | EP | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-20240342182-A1 | VIRAL PROPHYLAXIS TREATMENT METHODS AND PRE-EXPOSURE PROPHYLAXIS KITS | ELIAN LLC (US) | 2024-10-17 | — | — | US | claimed |
| WO-2024167952-A1 | OXIDATIVELY CLEAVABLE ORGANOPHOSPHATE DRUGS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2024-08-15 | — | — | WO | claimed |
| WO-2024097158-A1 | VIRAL PROPHYLAXIS TREATMENT METHODS AND PRE-EXPOSURE PROPHYLAXIS KITS | RAMIREZ CHRISTINA M (US) | 2024-05-10 | — | — | WO | claimed |
| US-20230310439-A1 | VIRAL PROPHYLAXIS TREATMENT METHODS AND PRE-EXPOSURE PROPHYLAXIS KITS | ELIAN LLC | 2023-10-05 | — | — | US | claimed |
| US-11696918-B2 | Viral prophylaxis treatment methods and pre-exposure prophylaxis kits | ELIAN LLC (US) | 2023-07-11 | — | — | US | claimed |
| EP-3930721-A1 | TREATMENT OF HERPES SIMPLEX WITH A COMBINATION OF VALACYCLOVIR AND FAMCICLOVIR | Elian LLC (US) | 2022-01-05 | — | — | EP | claimed |
| US-20200397791-A1 | VIRAL PROPHYLAXIS TREATMENT METHODS AND PRE-EXPOSURE PROPHYLAXIS KITS | ELIAN LLC | 2020-12-24 | — | — | US | claimed |
| US-9492456-B2 | Valomaciclovir polymorphs | EPIPHANY BIOSCIENCES, INC. (US) | 2016-11-15 | — | — | US | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| EP-2195319-A1 | VALOMACICLOVIR POLYMORPHS | Epiphany Biosciences, Inc. (US) | 2010-06-16 | — | — | EP | claimed |
| WO-2009126327-A1 | TREATMENT AND/OR PREVENTION OF MULTIPLE SCLEROSIS | EPIPHANY BIOSCIENCES, INC. (US) | 2009-10-15 | — | — | WO | claimed |
| WO-2009042081-A1 | VALOMACICLOVIR POLYMORPHS | EPIPHANY BIOSCIENCES, INC. (US) | 2009-04-02 | — | — | WO | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| EP-1058687-B1 | NUCLEOSIDES | MEDIVIR AB (SE) | 2003-12-10 | — | — | EP | claimed |
| EP-0880521-B1 | SYNTHESIS OF ACYCLIC NUCLEOSIDES | MEDIVIR AB (SE) | 2003-01-22 | — | — | EP | claimed |